Component

Etoposide

Etoposide. Species, exposure and limitations are retained in each linked claim.

2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

Where it participates (unsigned role)

  1. Mangiferin reduced etoposide-associated comet and micronucleus damage readouts.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/mangiferin-research/25380307.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "057a534a2074c49c824120d8e49fba7f4bde4d9d9b8bf15ef78f994083fdc8ea", "start_char": 0, "end_char": 1636, "text_sha256": "057a534a2074c49c824120d8e49fba7f4bde4d9d9b8bf15ef78f994083fdc8ea"}
    experimental_model
    Isolated human cord-blood mononuclear cells
    exposure
    Mangiferin and etoposide; concentration not specified in indexed abstract
    limitations
    Ex vivo DNA-damage and signaling assays; not evidence of clinical chemotherapy protection.
    nutrient_topic
    Mangiferin research collection; topical membership is not evidence of a direct dietary effect. · Mangiferin
    organism
    Homo sapiens
    plain_language
    DNA-damage measurements were lower in these isolated cells.
    primary_references
    [mangiferin-p25380307] Mangiferin activates the Nrf2-ARE pathway and reduces etoposide-induced DNA damage in human umbilical cord mononuclear blood cells. (2015). https://pubmed.ncbi.nlm.nih.gov/25380307/ DOI: 10.3109/13880209.2014.927890
    tissue_or_cell_type
    Cord-blood mononuclear cells

    Mangiferin: metabolism, signaling and nutrient connections (2026-09-17) · lines 588–599

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Isolated human cord-blood mononuclear cells · source_derived_draft · unverified_draft

    ### mangiferin-dna-damage Mangiferin reduced etoposide-associated comet and micronucleus damage readouts. Condition category: normal nutrient_topic: Mangiferin research collection; topical membership is not evidence of a direct dietary effect. plain_language: DNA-damage measurements were lower in these isolated cells. organism: Homo sapiens tissue_or_cell_type: Cord-blood mononuclear cells experimental_model: Isolated human cord-blood mononuclear cells limitations: Ex vivo DNA-damage and signaling assays; not evidence of clinical chemotherapy protection. exposure: Mangiferin and etoposide; concentration not specified in indexed abstract evidence_span: {"source_cache": "artifacts/mangiferin-research/25380307.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "057a534a2074c49c824120d8e49fba7f4bde4d9d9b8bf15ef78f994083fdc8ea", "start_char": 0, "end_char": 1636, "text_sha256": "057a534a2074c49c824120d8e49fba7f4bde4d9d9b8bf15ef78f994083fdc8ea"} [mangiferin-p25380307] Mangiferin activates the Nrf2-ARE pathway and reduces etoposide-induced DNA damage in human umbilical cord mononuclear blood cells. (2015). https://pubmed.ncbi.nlm.nih.gov/25380307/ DOI: 10.3109/13880209.2014.927890
    Complete structured claim and evidence
  2. Mangiferin did not attenuate etoposide cytotoxicity in HL-60 cells, despite protecting cord-blood mononuclear cells in the comparison.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/mangiferin-research/24374812.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "85ad69fcef2b1dd7b3842c076b89b76c9d54b73cc5843cefb3077642b6cb3451", "start_char": 0, "end_char": 1789, "text_sha256": "85ad69fcef2b1dd7b3842c076b89b76c9d54b73cc5843cefb3077642b6cb3451"}
    experimental_model
    Cell-line and primary mononuclear-cell comparison
    exposure
    Mangiferin 50 micromolar in principal assays; etoposide co-exposure
    limitations
    No clinical chemotherapy outcome. The abstract has an inconsistent mol/L unit in a later sentence; the 50 micromolar experimental concentration is explicit earlier.
    nutrient_topic
    Mangiferin research collection; topical membership is not evidence of a direct dietary effect. · Mangiferin
    organism
    Homo sapiens
    plain_language
    Protection varied with cell type.
    primary_references
    [mangiferin-p24374812] Mangiferin activates Nrf2-antioxidant response element signaling without reducing the sensitivity to etoposide of human myeloid leukemia cells in vitro. (2014). https://pubmed.ncbi.nlm.nih.gov/24374812/ DOI: 10.1038/aps.2013.165
    tissue_or_cell_type
    HL-60 leukemia cells and cord-blood mononuclear cells

    Mangiferin: metabolism, signaling and nutrient connections (2026-09-17) · lines 1303–1314

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cell-line and primary mononuclear-cell comparison · source_derived_draft · unverified_draft

    ### mangiferin-etoposide-cell-context Mangiferin did not attenuate etoposide cytotoxicity in HL-60 cells, despite protecting cord-blood mononuclear cells in the comparison. Condition category: normal nutrient_topic: Mangiferin research collection; topical membership is not evidence of a direct dietary effect. plain_language: Protection varied with cell type. organism: Homo sapiens tissue_or_cell_type: HL-60 leukemia cells and cord-blood mononuclear cells experimental_model: Cell-line and primary mononuclear-cell comparison limitations: No clinical chemotherapy outcome. The abstract has an inconsistent mol/L unit in a later sentence; the 50 micromolar experimental concentration is explicit earlier. exposure: Mangiferin 50 micromolar in principal assays; etoposide co-exposure evidence_span: {"source_cache": "artifacts/mangiferin-research/24374812.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "85ad69fcef2b1dd7b3842c076b89b76c9d54b73cc5843cefb3077642b6cb3451", "start_char": 0, "end_char": 1789, "text_sha256": "85ad69fcef2b1dd7b3842c076b89b76c9d54b73cc5843cefb3077642b6cb3451"} [mangiferin-p24374812] Mangiferin activates Nrf2-antioxidant response element signaling without reducing the sensitivity to etoposide of human myeloid leukemia cells in vitro. (2014). https://pubmed.ncbi.nlm.nih.gov/24374812/ DOI: 10.1038/aps.2013.165
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards